For example, high expression levels of TEAD1 correlate with poor clinical outcomes in prostate cancer [22], while knockdown of TEAD1 decreased cell growth in PC3 and disrupted acinar formation in a 3D culture system of RWPE1 [22, 23]. The gene discussed is TEAD1; the disease is prostate cancer.